SecBot SecBot
SECBOTREPLAY Home › Report › PCRX

PCRX · Kristen Williams, an officer of Pacira BioSciences, filed a Form 144…

Pacira BioSciences, Inc. · 144 filed Jun 4, 2026 at 09:48 ET

At the news

NEUTRALIMPACT 2/10

144 filed Jun 4, 2026 at 09:48 ET

Kristen Williams, an officer of Pacira BioSciences, filed a Form 144 intent to sell 10,259 shares of common stock, valued at approximately $228,468 based on a June 4, 2026 market price of $22.28. The shares were acquired through restricted stock vesting on June 3, 2026, as compensation. The sale is a routine post-vesting monetization by an officer, representing a small fraction of the company's $878M market cap, and does not signal material insider concern.

  • Officer Kristen Williams filed Form 144 to sell 10,259 shares of PCRX common stock
  • Proceeds estimated at ~$228,468 based on filing date price (~$22.28/share)
  • Shares acquired via restricted stock vesting on June 3, 2026 (compensation)
  • Sale executed through Fidelity Brokerage Services LLC

Replay the market's reaction

Step through every 5 minutes around the news, then see how it compares with similar events.

Subscribe for Full Access